CV Sciences CEO Joseph Dowling on Mainstreaming Cannabinoids

Written By: PlusCBD

Aug 1, 2021

Cannabidiol (CBD) is one of the major cannabinoids found in cannabis. CV Sciences (OTCQB: CVSI) operates in two divisions: its Consumer Products side which focuses on CBD products for the consumer market and its Drug Development division - the first medical solution it's working on is a nicotine cessation product using synthetic nicotine and cannabidiol. CEO Joseph Dowling on getting CBD out of the hands of the DEA; dialoguing with FDA based on science and years of data. Strong regulatory environment will grow the industry, not restrict it. Using expertise from fish oil industry.

Comments

Be the first to comment!

ADD COMMENT